| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4323735 | P | Lipophilicity, logP of compound | 12 | small-molecule physicochemical format | Scientific Literature | |||
| 2. | ALA4323740 | B | Binding affinity to recombinant full length human CYP51 expressed in Escherichia coli incubated for 30 sec using [3H] labelled substrate by HPLC analysis | Homo sapiens | 12 | assay format | Scientific Literature | ||
| 3. | ALA4323741 | B | Binding affinity to recombinant full length human CYP51 expressed in Escherichia coli assessed as fold change in dissociation constant incubated for 30 sec using [3H] lanosterol as substrate by HPLC analysis relative to VFV | Homo sapiens | 5 | assay format | Scientific Literature | ||
| 4. | ALA4323742 | B | Inhibition of recombinant full length human CYP51 expressed in Escherichia coli incubated for 1 min using [3H] lanosterol as substrate by HPLC analysis | Homo sapiens | 12 | assay format | Scientific Literature | ||
| 5. | ALA4323743 | B | Inhibition of recombinant full length human CYP51 expressed in Escherichia coli at inhibitor/enzyme ratio 50/1 incubated for 1 hr using [3H] lanosterol as substrate by HPLC analysis relative to control | Homo sapiens | 12 | assay format | Scientific Literature | ||
| 6. | ALA4323744 | B | Inhibition of recombinant full length human CYP51 expressed in Escherichia coli at inhibitor/enzyme ratio 25/1 incubated for 1 hr using [3H] lanosterol as substrate by HPLC analysis relative to control | Homo sapiens | 12 | assay format | Scientific Literature | ||
| 7. | ALA4323745 | B | Inhibition of recombinant full length human CYP51 expressed in Escherichia coli incubated for 1 hr using [3H] lanosterol as substrate by HPLC analysis | Homo sapiens | 12 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!